Nephros NEPH
NASDAQ NEPH
$3.74 +0.07 (+1.85%)
As of: Oct 2, 2026 · 10:34 AM EDT

Nephros (NEPH) Liabilities from Discontinued Operations (2021)

Updated

Nephros (NEPH) posted Liabilities from Discontinued Operations of $72,000 for Q4 2021.

Analysis

Nephros (NEPH) Liabilities from Discontinued Operations (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Nephros 40.29 Mn 21.01 Mn 4.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 72,000.00
API Access

Nephros Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=NEPH&period=max&api_key=YOUR_API_KEY